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Abstract: Periodontitis is a common infectious disease characterized by loss of tooth-supporting
structures, which eventually leads to tooth loss. The heavy burden of periodontal disease and its
negative consequence on the patient’s quality of life indicate a strong need for developing effective
therapies. According to the World Health Organization, 10–15% of the global population suffers from
severe periodontitis. Advances in understanding the etiology, epidemiology and microbiology of
periodontal pocket flora have called for antibacterial therapeutic strategies for periodontitis treatment.
Currently, antimicrobial strategies combining with polymer science have attracted tremendous
interest in the last decade. This review focuses on the state of the art of antibacterial polymer
application against periodontal pathogens and biofilms. The first part focuses on the different
polymeric materials serving as antibacterial agents, drug carriers and periodontal barrier membranes
to inhibit periodontal pathogens. The second part reviews cutting-edge research on the synthesis and
evaluation of a new generation of bioactive dental polymers for Class-V restorations with therapeutic
effects. They possess antibacterial, acid-reduction, protein-repellent, and remineralization capabilities.
In addition, the antibacterial photodynamic therapy with polymeric materials against periodontal
pathogens and biofilms is also briefly described in the third part. These novel bioactive and
therapeutic polymeric materials and treatment methods have great potential to inhibit periodontitis
and protect tooth structures.
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1. Introduction
Periodontitis is a dental plaque (bacteria)-induced, and host-mediated, breakdown of soft and
hard tissues surrounding the teeth [1]. It is a persistent disease with no appreciable decrease in the
prevalence of periodontitis in any of the world’s regions between 1990 and 2010 [2]. In 1999, nearly
35% of individuals ≥30 years of age showed signs of periodontitis in the United States [3]. Severe
periodontitis was reported as the sixth most prevalent chronic condition in 2010, affecting 10.8% of the
population 15–99 years of age, or 743 million people [2]. Furthermore, the prevalence of periodontal
disease increases with age. More than 70% of adults aged 65 or older are diagnosed with some form of
periodontal disease [4].
Microbial biofilms are the aggravative factor of periodontitis [5]. The conventional treatment
for periodontitis involves mechanical processing (such as supragingival scaling, subgingival scaling,
and root planing) advantageously accompanied by the adjuvant administration of antibiotics, which
can be applied by systemic or local administration [6]. The periodontal pocket provides a natural
reservoir, which is easily accessible for the insertion of a delivery device. Therefore, intra-pocket
drug delivery systems are highly desirable due to the potentially lower incidence of undesirable side
effects, improved efficacy and enhanced patient compliance. Recent progress in polymer sciences
have produced bioactive polymeric materials, which can be modified to meet pharmacological
and biological requirements [7]. First, polymers can possess strong antibacterial properties against
periodontal pathogens and could be used as an alternative to low molecular weight antimicrobial
agents in periodontitis treatment due to their low cost, versatility, and processability [8–11]. Second,
polymeric materials can serve as intra-pocket drug delivery devices for the treatment of periodontitis
in various formulations and forms. Third, polymeric materials can be applied in fabrication of
biodegradable periodontal membranes for guided tissue regeneration (GTR) [12–16]. The periodontal
membrane acts as a mechanical barrier which protects the clot, and allows periodontal ligament
and bone tissue to selectively repopulate the root surface during healing [12]. The main risk that
contributes to unsuccessful tissue regeneration by GTR membrane treatment is the action of periodontal
pathogens. Therefore, multifunctional GTR membranes were recently developed to possess not only
barrier and tissue regenerative properties, but also antibacterial effects against periodontal pathogens.
Several meritorious reviews on polymeric materials have described their antibacterial effects against
pathogenic microorganisms [17–19], drug delivery capabilities [20–22] and periodontal regeneration
for periodontitis treatment [23–25], which is not repeated here.
Tooth-colored polymeric composites and bonding agents are the primary materials for restoring
tooth cavities [26–30]. This is because advances in polymer chemistry and filler particle compositions
have enhanced the composite restoration properties [31–36]. As the world population ages, there is an
increasing trend of root caries in senior people. Root caries can be treated with Class-V restorations.
However, they often have subgingival margins which are difficult to clean and can provide pockets for
periodontal bacterial growth. This in turn leads to the worsening of periodontitis and the damage of the
periodontal attachment. To make matters worse, the currently available dental polymer-based Class-V
composites not only have no antibacterial effect, but actually accumulate more biofilms and plaque than
other materials such as metals. The present article reviews new developments in polymeric materials
for periodontitis treatment, periodontal tissue regeneration and Class-V restorations, focusing on
bioactive and therapeutic effects against periodontal pathogens and biofilms.
2. Polymeric Materials as Drug Carrier for Combating Periodontal Biofilm
The origin of periodontitis is closely related with a dramatic shift from a symbiotic microbial
community to a dysbiotic microbial community that is mainly composed of anaerobic genera [37].
As the treatment of periodontitis mainly focuses on the elimination of the periodontal pathogens
or biofilms from the tooth surface, antibiotics are commonly used to treat the disease. Therefore,
intra-pocket drug delivery systems are highly desirable because they can maintain effective high levels
of antibiotics in the gingival crevicular fluid for a prolonged period of time [7]. Meanwhile, they
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have lower risks of undesirable side effects, superior efficacy and enhanced patient compliance [7].
Due to the relatively low price, higher stability, nontoxicity, biocompatibility, nonimmunogenicity and
biodegradability, a variety of polymers are investigated as drug carriers in various formulations
and forms such as fibers [38–41], strips [42], films [43,44], gels [45,46], micro-particles [47–49],
nanoparticles [11,50–52], and vesicular system [53,54]. Table 1 shows various polymer-based local drug
delivery systems delivering a variety of antibiotics, such as metronidazole, doxycycline, tetracycline
and secnidazole, for combating periodontal pathogens.
Table 1. Polymeric materials as drug delivery systems for combating periodontal pathogens.
Polymer/Polymer-Based
Product

Drug/Antibiotics

Periodontal Pathogens

References

Chitosan

Chlirhexidine (Chx)
gluconate Taurine
(Amino acid)

P. gingivalis

[9]

Cellulose acetate phthalate
and Pluronic F-127 (CCAP)

Metronidazole

>P. gingivalis

[55]

PLGA

Secnidazole (SC)
Doxycycline
hydrochloride (DH)

P. gingivalis
F. nucleatum

[56]

Arestin®

Minocycline

>A. actinomycetemcomitans

[57]

Polyester

Doxycycline hyclate
Metronidazole

>P. gingivalis

[46]

Badam gum
Karaya gum
Chitosan

Moxifloxacin

>A. actinomycetemcomitans

[58]

Atridox®

Doxycycline hyclate

P. gingivalis
F. nucleatum

[59,60]

Chip

PLGA

Chlorhexidine (CHX)
CHX digluconate

P. gingivalis

[61]

Strip

Hydroxypropylcellulose

Green tea catechin

P. gingivalis
Prevotella spp.

[62]

Cube

poly(glycerol sebacate) (PGS)

Berbereine chlorhexidine

P. gingivalis
A. actinomycetemcomitans

[63]

Microparticles

Gelatin

Doxycycline

P. gingivalis

[64]

PLGA
Polymersomes

Minicycline
Metronidazole
Doxicycline

P. gingivalis
T. forsythia
T. denticola
P. gingivalis

[65,66]

PEGylated PLGA

Minocycline

A. actinomycetemcomitans

[67]

PLGA

H.madagascariensis leaf
extract (HLE)

Prevotella species

[68]

Type

Film

Gel

Nanoparticles

Gels as semisolid systems could easily apply to the site of action with fast drug release rate,
adhere to wide area of mucosa in the dental pockets, and maintain the concentration of antibiotics
due to their bio-adhesive characteristics [69]. Polymers such as chitosan, poly (DL-lactide-co-glycolide)
(PLGA) and polyacrylic acid are used for the preparation of gels. Gad et al. formulated PLGA “in
situ implants” containing secnidazole and doxycycline by a non-solvent-induced phase separation
mechanism [56]. The antibacterial evaluation against Porphyromonas gingivalis (P. gingivalis) showed
that implants with 25% PLGA showed a greater zone of inhibition than a commercial control Atridox® ,
which is a locally delivered antimicrobial product containing doxycycline hyclate [56].
In addition, films are widely used for intra-pocket delivery. Films could be fabricated either by
solvent-casting or direct milling. The drugs are distributed throughout the polymer and released
by diffusion and/or matrix dissolution or erosion [70]. Importantly, the shape of the film can
be easily adjusted according to the dimensions of the intra-pocket. Solvent-cast PLGA films
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were aminolyzed and modified by a Layer-by-Layer technique to obtain a nano-layered coating
with poly(sodium4-styrenesulfonate) and poly(allylamine hydrochloride) as polyelectrolytes [71].
A water-soluble antibiotic, metronidazole (MET), was incorporated to successfully endow the film
with excellent antibacterial properties against the keystone periodontal pathogen P. gingivalis, without
compromising the in vitro biocompatibility.
Recently, intensive efforts are being made all over the world to improve the effectiveness of
delivery systems. Due to the rapid advancement in nanotechnology, nanoparticulate systems provide
several advantages as compared with other delivery systems. A nanoparticle is defined as a particle
that has a size range of approximately 1–100 nm, with properties that are not shared by non-nanoscale
particles with the same chemical composition. Regarding the application in periodontitis, first, it is
easier for nanoparticle carriers to access deeper into the site of tooth furcation and periodontal pocket
regions under gum line, while it may be inaccessible for other delivery systems [21]. Second, frequency
reduction of administration in the periodontal pockets by applying nanoparticles would enhance
the therapeutic effects and reduce side effects [7]. Third, nanoparticles possess better stability in
biological fluid and high dispersibility in an aqueous medium [7]. Sadat et al. prepared both PLGA
and PEGylated PLGA nanoparticles by various methods, such as single and double solvent evaporation
emulsion, ion pairing, and nanoprecipitation [67]. Antibacterial properties against Aggregatibacter
actinomycetemcomitans (A. actinomycetemcomitans) showed that the encapsulation of minocyline into the
polymeric nanoparticles improved the antibacterial efficiency by two folds, compared to that of the free
drugs. This was possibly due to better penetration of the nanoparticles into bacterial cells and better
delivery of minocyline to the site of action [67]. Besides encapsulation, drugs can also be doped onto
the surface of polymeric nanoparticles due to the specific surface chemistry. A novel type of polymeric
nanoparticles, PolymP-n active nanoparticles, was recently developed, with potential for periodontal
regeneration [72]. Due to the surface chemistry of the nanoparticles, containing functional groups with
sequences of anionic carboxylate (i.e. COO− ), it was possible to dope metal cations (in this case calcium,
zinc and silver) and antibiotics (doxycycline), with potential antibacterial activity [73]. A multispecies
periodontal biofilm was developed by using Streptococcus oralis (S. oralis), Actinomyces naeslundii
(A. naeslundii), Veillonella parvula (V. parvula), Fusobacterium nucleatum (F. nucleatum), P. gingivalis and
A. actinomycetemcomitans to investigate the antibacterial properties of polymeric PolymP-n active
nanoparticles doped with different substances: zinc, calcium, silver and doxycycline [73]. A similar
biofilm formation was observed, although reductions in bacterial viability were detected in biofilms
in contact with the different nanoparticles, and were more pronounced with silver and doxycycline
nanoparticles. PolymP-n nanoparticles with doxycycline resulted in unstructured biofilm formation
and significantly lower colony units of the six species, compared with the other specimens and
controls [73]. However, with the emergence and increase of microbial resistance to antibiotics, further
studies should investigate not only antibiotic-free delivery systems but also antimicrobial peptides
(AMPs) for treating periodontal infections. Bacterial flora is controlled initially by the innate immune
system of oral epithelia, saliva and gingival crevicular fluid, which are rich with AMPs [74]. AMPs
such as LL37 and β-defensins have demonstrated excellent antibacterial efficacy against periodontal
pathogens [75]. Therefore, the existing and newly-identified AMPs may be promising for therapeutic
uses in treating periodontal disease, and they may serve as templates for peptides and peptide-mimetics
with improved therapeutic efficacy [74].
3. Antibacterial Polymeric Materials Against Periodontal Pathogens
Although polymers can serve as matrix materials holding the antibacterial agents for treatment
of infectious disease, the development of polymers with antimicrobial activity themselves is also
an important area of research. In addition, increasing antibiotic drug-resistance of microorganisms
has drawn considerable attention toward the development of new types of antibacterial agents.
Several antibacterial polymers are applied in infectious diseases caused by pathogenic microorganisms.
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However, their antibacterial properties against periodontal pathogens or biofilms are rarely
investigated [9,76].
Chitosan, a linear polycationic hetero polysaccharide copolymer, exhibits an excellent capacity of
antimicrobial efficacy. The contact between negatively charged cell wall and positively charged chitosan
can alter the cell wall permeability and eventually lead to the complete cell wall disruption and cell
death. Molecular weight, concentration, and hydrophilic/hydrophobic characteristics of chitosan also
play some role in antibacterial efficacy [77]. Chitosan showed antimicrobial activity against periodontal
pathogens P. gingivalis, A. actinomycetemcomitans and Prevotella intermedia (P. intermedia) with quick and
efficient bactericidal activity [78]. Similar excellent antibacterial activity of chitosan against P. gingivalis
and A. actinomycetemcomitans was also reported by Arancibia et al. [79]. Furthermore, Sarasam et al.
confirmed that chitosan-mediated antibacterial activity was contact-dependent; therefore, blending
chitosan with other components such as polycaprolactone (PCL) compromised its antibacterial activity
against A. actinomycetemcomitans [80]. The possible explanation is that the surface characteristics of
chitosan, such as surface roughness and charge distribution, may be altered when blending with PCL,
thereby decreasing the antibiotic performance.
Recent efforts developed a new class of antimicrobial agents, termed “structurally nanoengineered
antimicrobial peptide polymers” (SNAPPs), as shown in Figure 1. They exhibited sub-µM activity
against Gram-negative bacteria Acinetobacter baumannii (A. baumannii) [81]. It is possible that in addition
to putative periodontal pathogens, non-oral bacterial species such as A. baumannii may also play a role
in the etiopathogenesis of periodontal diseases [82]. The antibacterial activity of SNAPPs proceeds via
a multimodal mechanism of bacterial cell death by outer membrane destabilization, unregulated ion
movement across the cytoplasmic membrane and induction of the apoptotic-like death pathway [81].
Therefore, SNAPPs showed great promise as low-cost and effective antimicrobial agents in combating
the growing threat of Gram-negative bacteria, which is prevalent in periodontitis.
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Metronidazole (MET) is widely used to treat periodontitis in patients for whom mechanical
debridement is not successful or possible [85]. Xue et al. developed MET-loaded electrospun PCL
nanofiber membranes. A wide range (1–40 wt %) of MET was incorporated into the membrane.
An in vitro antibacterial effect against F. nucleatum showed clear inhibition zones around the
membranes. GTR membranes with 30 wt % MET showed excellent comprehensive properties.
However, the release time of metronidazole was only a few days [86]. To sustain the drug release
for a longer time, gelatin was added into PCL in the same electrospun system to form a PCL/gelatin
nanofiber membrane [87]. As effective MET carriers, PCL/gelatin membranes with various contents
of MNA showed an approximately 60% release of MET within one week. This was followed by
a sustained release of up to three weeks, which was predominantly controlled by diffusion and
gelatin degradation [87]. In addition, an efficient anti-infective GTR membrane was developed by
doping drug-loaded clay nanotube into electrospun PCL/gelatin microfibers [88]. By combining
the drug-loading capability of nanotubes and direct drug loading into electrospun microfiber
matrix, composite membranes with a three-week sustained drug release capability were realized.
This extended release prevents the colonization of F. nucleatum over period of three weeks [88].
This three-week prolonged drug release is considered to be an optimal treatment time period.
Bittino et al. fabricated a novel functionally-graded periodontal membrane containing MET
with a spatially designed layer structure via sequential electrospinning [89]. As shown in Figure 2,
the functionally-graded periodontal membrane consisted of a core layer (CL) and two functional
surface layers (SLs) interfacing with bone (nano-hydroxyapatite, n-HAp) and epithelial (MET)
tissues. This multi-layered electrospun GTR membranes had nano-sized hydroxyapatite for
osteoconductive/inductive behavior, and metronidazole to combat periodontal pathogens. Other
antibiotics such as amoxicillin, tetracycline, chlorhexidine and doxycycline were also incorporated
into polymeric membrane with therapeutic properties [90–93]. Composite GTR membranes
with polytetrafluoroethylene (ePTFE) and collagen were loaded with chlorhexidine and inhibited
A. actinomycetemcomitans, allowing the attachment of periodontal ligament cells [92]. Similar results
were obtained when amoxicillin and tetracycline were incorporated into GTR membranes [94].
Besides antibiotic addition, metal or metallic oxide such as silver, zinc, copper and zinc oxide
nanoparticles were also incorporated into the GTR membranes. For example, zinc oxide (ZnO)
nanoparticles not only introduced an antibacterial activity, but also improved the osteoconductivity of
the periodontal membrane [12]. Nasajpour et al. developed a GTR membrane through electrospinning
methods with a dispersed solution of ZnO within a polymeric carrier PCL. Incorporation of 0.5% (w/v)
ZnO nanoparticles provided antibacterial effects against periodontal pathogens P. gingivalis, while
supporting the viability and the osteodifferentiation of the seeded periodontal ligament stem cells,
without negatively impacting their biocompatibility feature [12]. Zinc phosphate was also loaded
into the GTR membrane by an immersion method. The zinc phosphate mineralized membranes
possessed a strong antibacterial effect against A. actinomycetemcomitans [95]. A recent study developed
a chitosan/polyurethane (CSP) nanofibrous membrane with silver nanoparticles (AgNPs) in the
membrane [96]. The antibacterial effects of the membrane against P. gingivalis was maintained when
the AgNP level was adjusted to be at a nontoxic level.
It was reported that high drug ionic strength and rapid solvent evaporation favored the presence
of the drug on the membrane surface, which led to a high initial burst release, thereby avoiding
and/or eliminating biofilm formation [97]. However, the high burst release and short release period
could not effectively prevent bacterial infections. Hence, it is highly desirable to develop novel GTR
membranes with sustained and controlled release of antibacterial agents, particularly for patients with
a predisposition to such complications: smokers, patients with diabetes mellitus, etc. [98].
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lower mineral content and a higher amount of organic materials [114]. Therefore, root caries lesions
may occur on all exposed root surfaces but are mainly found in biofilm retention sites [114]. Root
caries can be treated with a Class-V restoration, whose margins are often subgingival, which can
hinder cleaning and provide pockets for bacterial growth, thus gradually resulting in the loss of the
periodontal attachment of the tooth. Indeed, it is well-established that microbial biofilms are the
primary etiological factor that causes periodontitis [5]. Recent research demonstrated that P. gingivalis,
P. intermedia and A. actinomycetemcomitans are the three major bacterial species that contribute to
periodontitis and peri-implantitis in subgingival plaque [115]. In the periodontal pockets, these
bacteria can generate virulence factors that lead to the gradual loss of the supporting bone [115].
In addition, Prevotella nigrescens (P. nigrescens) is associated with both healthy and diseased conditions
of the periodontium [116]. F. nucleatum is correlated with the progress in periodontitis [117] and
can enhance the invasion into human gingival epithelial and endothelial cells by P. gingivalis [118].
Furthermore, Enterococcus faecalis (E. faecalis) is regarded as an endodontic pathogen and also detected
in subgingival plaque and saliva of patients with chronic periodontal disease [119].
Therefore, these six species were selected in a recent study [120]. A polymeric composite for
Class-V tooth cavity restorations was developed with therapeutic functions to combat these six species
of pathogens related to the start and the exacerbation of periodontitis [120]. The polymeric matrix in
the composite was composed of ethoxylated bisphenol A dimethacrylate (EBPADMA) and pyromellitic
dianhydride glycerol dimethacrylate (PMGDM) at a 1:1 mass ratio (referred to as EBPM). A novel
antibacterial monomer dimethylaminohexadecyl methacrylate (DMAHDM) was added at a mass
ratio of 3%. DMAHDM incorporation did not compromise the mechanical properties of polymeric
composite. The flexural strength of EBPM + 3% DMAHDM was similar to that of a commercial control
composite that had no antibacterial effect [120]. Static single-species biofilms of six types of pathogens
were used to evaluate the antibacterial effects of polymeric composites with DMAHDM incorporation.
For all six species, incorporating 3% DMAHDM into EBPM composite decreased the biofilm CFU
by several orders of magnitude, compared to the commercial control and the 0% DMAHDM group
(p < 0.05). DMAHDM composite reduced the CFU of different bacterial species differently, some by
slightly less than 3 log, others by more than 3 log (as shown in Figure 3) [120]. The killing efficacy of
DMAHDM composite against the six species was: E. faecalis < F. nucleatum < P. nigrescens = P. intermedia
< A. actinomycetemcomitans < P. gingivalis. Furthermore, the biomass and the polysaccharide production
by biofilms were also reduced on the EBPM composite with 3% DMAHDM, compared to control
composite [120].
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Salivary protein adsorption on the surface is required for pellicle formation and is a prerequisite
Salivary protein adsorption on the surface is required for pellicle formation and is a prerequisite for
for oral bacteria adherence [121]. Based on this mechanism, a protein-repellent composite was
oral bacteria adherence [121]. Based on this mechanism, a protein-repellent composite was developed
developed using 2-methacryloyloxyethyl phosphorylcholine (MPC). MPC is a methacrylate with a

using 2-methacryloyloxyethyl phosphorylcholine (MPC). MPC is a methacrylate with a phospholipid
polar group in the side chain [122]. MPC has strong protein-repellency, and has been incorporated
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Previous studies tested single species biofilms [128]. However, single species models are
not representative of natural biofilms where multispecies communities are by far the most
predominant [129]. The eradication of multispecies biofilms is more difficult to achieve than
single species, as multispecies biofilms are more highly resistant to antimicrobial agents than single
species [130]. Furthermore, the biofilm composition may influence the outcome of periodontitis
treatments [131] and the killing efficacy of antibacterial agents [130].
Therefore, a recent study investigated the effects of the number of species (from 1 to 9) in the
periodontal biofilm on the inhibition efficacy of the composite [132]. Moreover, the effect of dual agents
(MPC + DMAHDM) versus single agent on the inhibition efficacy was investigated as a function of
the number of species in the biofilm for the first time. Figure 5 illustrates the anti-biofilm strategy.
The bioactive composite reduced protein adsorption by an order of magnitude and greatly reduced
biofilm viability. It decreased the biofilm CFU by more than three orders of magnitude for all four
types of periodontal biofilms (single-species, three-species, six-species, and nine-species biofilms),
compared to the control composite. With increasing the biofilm species from 1 to 9, the antibacterial
efficacy of DMAHDM composite decreased; the folds of CFU reduction decreased from 947 to 44 folds.
In contrast, the DMAHDM+MPC composite maintained a CFU reduction folds of greater than 3000,
showing a similarly high antibacterial potency from 1 to 9 species in the biofilms.
Therefore, DMAHDM composite was more effective in inhibiting single species biofilm; the
inhibition efficacy decreased with increasing the number of species in the biofilms. Adding MPC into
the DMAHDM composite increased the efficacy against multi-species biofilms, achieving nearly the
same high efficacy against biofilms with 1–9 species. The novel nanocomposite containing dual agents
(MPC + DMAHDM) with potent antibiofilm and protein-repellent functions is promising for Class-V
restorations to treat root caries, inhibit periodontal pathogens, and protect the periodontal tissues.
To enhance the antibacterial efficacy, Xiao et al. incorporated nanoparticles of silver (NAg) into the
aforementioned MPC + DMAHDM composites to inhibit pathogens such as A. actinomycetemcomitans,
F. nucleatum and P. gingivalis [133]. There are several advantages for NAg incorporation into polymeric
nanocomposite. (1) The small particle size of NAg (2.6 nm) yielded a relative high surface area to
mass ratio, which enabled a small quantity of NAg to be sufficient for the composite to be strongly
antibacterial. This avoided the need to use a high mass fraction of NAg and compromised the
nanocomposite’s mechanical properties and esthetics [134]. (2) Ag is known to have a superior
biocompatibility and low toxicity to humans. (3) Resins containing NAg exhibited long-lasting
antimicrobial properties. For example, a previous study demonstrated that NAg-containing resins
showed antibacterial activity even after 12 months of water-aging [135]. (4) Ag have less possibility
for causing bacterial resistance than antibiotics, which alleviates the drug-resistance concern [136].
(5) NAg is capable of long-distance killing of bacteria due to the release and diffusion of the Ag ions.
This is expected to be useful to inhibit the suspended bacteria in the periodontal pockets away from
the composite surface. Indeed, the combination of MPC, DMAHDM and NAg achieved the reduction
in biofilm CFU by nearly five orders of magnitude, which is much greater than those achieved by
previous antibacterial dental composites [120,127].
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A. actinomycetemcomitans, F. nucleatum and Parvimonas micra (P. micra) were used to represent
periodontal pathogens, and Enterococcus faecium (E. faecium) and E. faecalis were selected as endodontic
pathogens. Therefore, eight types of single-species biofilms were formed on resins. Adding 5%
DMAHDM and 30% NACP into the adhesive resin did not negatively affect the dentin bond strength.
Biofilm CFU was reduced by nearly three orders of magnitude via the therapeutic resin. The inhibition
efficacy via DMAHDM-containing resin was ranked as: P. gingivalis > A. actinomycetemcomitans >
P. intermedia > P. nigrescens > F. nucleatum > P. micra > E. faecalis > E. faecium. Biofilm biomass, metabolic
activity and polysaccharide were also greatly reduced via DMAHDM [138].
In addition, three bioactive agents (NACP for remineralization, MPC for protein-repellency,
and DMAHDM for anti-biofilm activity) were combined into a polymeric bonding agent (PEHB)
to suppress periodontal pathogens [139]. PEHB with 5% DMAHDM showed a strong antibacterial
function and protein-repellent properties. The use of dual agents, 5% DMAHDM + 5% MPC, achieved
a greater killing efficacy against P. gingivalis single-species biofilm than against multi-species biofilm.
However, this novel polymeric bonding agents still showed great reduction in multispecies biofilm
growth, metabolic activity and polysaccharide production, yielding three orders of magnitude in CFU
reduction [139].
The mechanism of contact-inhibition implied that the polymer surface was separated from the
overlaying biofilm by the presence of the salivary protein pellicles on the polymer surface. This would
reduce the extent of contact, and hence result in the decreased contact-inhibition efficacy. Therefore,
because of the protein-repellency of the MPC, it helped diminish protein coverage on the polymer
surface, thus exposing more polymer surface with quaternary amine N+ sites, thereby promoting the
contact-inhibition ability. Therefore, the dual use of DMAHDM and MPC in the dental polymer could
work synergistically to maximize the periodontal bacteria inhibition capability.
Besides the antibacterial agents, NACP were also incorporated in polymeric bonding agents [140–142].
While having little antibacterial activity, the NACP composite was “smart” and could greatly increase
the Ca and P ion release at a cariogenic low pH, when such ions were most needed to inhibit caries [143].
Indeed, a previous study showed that an NACP nanocomposite successfully remineralized enamel
lesions, and achieved an enamel lesion remineralization efficacy that was four-fold greater than that of a
commercial fluoride-releasing control [144]. In addition, a previous study showed that NACP composite
could be recharged repeatedly with Ca and P ions, which ensured that it could continuously release Ca
and P ions to provide long-term remineralization [145]. In Class-V restorations, these Ca and P ions from
the composite are expected to help remineralize tooth roots, reduce root sensitivity, neutralize biofilm
acids, and protect the root structures.
Currently, several contemporary dental adhesives have been reported to possess a favorable
“immediate” bond strength to enamel and dentin. However, the clinical longevity of the bonded
restorations is still too short, mainly due to the degradation of the adhesive tooth-composite interface,
especially for Class-V restorations with subgingival margins. First, in comparison with bonding
composite resins to enamel, bonding to cervical dentin is less predictable due to the relatively low
density and oblique orientation of dentinal tubules in cervical dentin in Class-V restoration [146].
Second, marginal openings are located most frequently at the dentin/cementum margins when
Class-V cavities are restored with composite-based materials. Besides polymerization stress, forces
that result from volumetric changes due to temperature fluctuations and non-uniform deformation of
restoratives and the tooth substance during functional loading also repeatedly stress the restorative
interface [147]. Third, the subgingival cavity is difficult to dry. The inadequate air drying could result
in too much residual solvent in the adhesive and in the hybrid layer, which would reduce the bonding
durability [148]. Therefore, advanced restorative techniques such as the incremental filling technique
with the application of flowable materials as an intermediate layer are used to improve the marginal
adaptation of composites to the dentin/cementum margin in Class-V restoration [147].
Investigation of the toxicity of the antimicrobial monomers is a prerequisite before their use in
oral restorations. Imazato et al. indicated that the first QAM for dental application, MDPB, exhibited
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a low level of toxicity to human pulpal cells, similar to the diluent resin monomer triethyleneglycol
dimethacrylate (TEGDMA) [101]. Although a previous study demonstrated that the increasing
monomer concentration and increasing chain length of QAMs would increase the cytotoxicity, QAMs
with chain lengths from 3 to 18 were shown to have less cytotoxicity than BisGMA [149]. At monomer
concentrations of ≤2 µg/mL, all the tested QAMs with CL ≤ 16 had cytotoxicity matching that of
HEMA and TEGDMA [149]. Clinically, a typical tooth cavity would use approximately 20 µg of the
bonding agent. In the unrealistic worst-case scenario, assume that all 20 µg were leached out in one
day [149]. Human saliva flow is approximately 1000–1500 mL/day [150]. This would yield a monomer
concentration of 0.02 µg/mL, which would be acceptable for clinical applications.
7. Polymeric Materials for Antibacterial Photodynamic Therapy Against Periodontal Pathogens
Currently, mechanical debridement and antibiotic therapy are still the major approaches for
periodontitis treatment. However, conventional tools can hardly reach deep periodontal pockets.
The overuse of antibiotics could lead to drug-resistant bacteria. In the past decade, antibacterial
photodynamic therapy (aPDT) gradually attracted the attention of researchers, and several studies
on the efficient clearance of periodontal pathogens or biofilms using aPDT were reported [151,152].
aPDT is a promising antibacterial therapeutic approach for periodontal pathogens to make up for
the aforementioned shortcomings. aPDT involves three components: photosensitizer (PS), light,
and oxygen. For periodontal pathogens, PS should have properties of good biocompatibility, high
selectivity, high solubility, light stability, high quantum yield of reactive oxygen species (ROS)
generation having positive charge, and causing no staining on gingiva [153,154]. The ideal irradiation
light should be at red to near-infrared wavelengths to obtain a deeper penetration. As shown in
Figure 6, the mechanism of aPDT is that, after being excited by a specific wavelength of light, the PS
converts energy or electrons to generate ROS in the presence of molecular ground triplet state oxygen,
thus leading to bacterial cell death [155]. Generally, the bactericidal effect of aPDT can be attributed
to oxidative damage, including DNA damage and cell membrane system damage (biofilm matrix
Int.
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Recently, attention has been paid to biodegradable polymeric materials in PDT studies due to their
Recently, attention has been paid to biodegradable polymeric materials in PDT studies due to
most remarkable properties of biocompatibility and low toxicity [157]. Regarding aPDT, application of
their most remarkable properties of biocompatibility and low toxicity [157]. Regarding aPDT,
polymeric materials carries several advantages: (1) increasing positive charge of PS and enhancing
application of polymeric materials carries several advantages: (1) increasing positive charge of PS
the binding between PS and bacteria; (2) reducing aggregation of PS and increasing its bioavailability;
and enhancing the binding between PS and bacteria; (2) reducing aggregation of PS and increasing
and (3) serving as a carrier or scaffold with good biocompatibility and biodegradability.
its bioavailability; and (3) serving as a carrier or scaffold with good biocompatibility and
biodegradability.
Periodontitis is a chronic infectious disease associated with Gram-negative bacteria. The cell
envelope of Gram-negative bacteria consists of an outer membrane, a thinner peptidoglycan layer
and a cytoplasmic membrane. Lipopolysaccharides (LPS) and the porins, the two main components
of the outer membrane, have the membrane barrier protection to allow only certain molecules to pass
through [158]. Negatively charged LPS molecules have a strong affinity for cations or cationic group.
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Periodontitis is a chronic infectious disease associated with Gram-negative bacteria. The cell
envelope of Gram-negative bacteria consists of an outer membrane, a thinner peptidoglycan layer and
a cytoplasmic membrane. Lipopolysaccharides (LPS) and the porins, the two main components of
the outer membrane, have the membrane barrier protection to allow only certain molecules to pass
through [158]. Negatively charged LPS molecules have a strong affinity for cations or cationic group.
In contrast, anionic and neutral group cannot be up-taken by bacteria, which hinders the effective
implementation of aPDT [159]. Thus, cationic PSs are considered to be used to overcome the initial
difficulty in aPDT.
Figure 7 depicts different strategies of PS modification by polymers for bactericidal effect
enhancement. In a recent study, compared with free methylene blue (MB) alone, MB-loaded PLGA
cationic nanoparticles showed greater bactericidal effect on microorganisms in both planktonic and
biofilm phase from human dental plaque samples collected from untreated patients with chronic
periodontitis (Figure 7A) [160]. With a concentration of 50 mg/mL, exposure to red light for 5 min with
a power density of 100 mW/cm2 , MB-loaded PLGA cationic nanoparticles reduced bacterial viability
by approximately 60% from the planktonic PDT and 48% from the biofilm PDT [160]. In addition,
the effect of this MB-NP-based aPDT as an adjunctive treatment combining with ultrasonic scaling (US)
and scaling and root planning (SRP) showed a slightly better outcome than using US + SRP alone [161].
All clinical parameters including visible plaque and gingival bleeding indexes (GBI), bleeding on
probing and probing pocket depth in both groups showed the greatest improvement one month later.
However, US + SRP + aPDT showed a greater effect (28.82%) on GBI compared with US + SRP at three
months [161]. Similarly, indocyanine green-loaded nanospheres coated with chitosan (ICG-Nano/c)
was designed to cope with the clearance of P. gingivalis. ICG-Nano/c could adhere to the surface of
P. gingivalis and significantly reduced the number of P. gingivalis by an order of 2 log10 (96.71%) to
4 log10 (99.99%) [162,163]. In addition, the strategy of intermittent irradiation with air cooling also
improved therapeutic penetration and prevented tissue thermal damage [162]. This was probably
because the PLGA provided positive charge and helped aPDT to produce a sustained effect on the
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Figure 7. The various strategy of photosensitizer (PS) modification by polymeric materials to enhance

Figure 7. The various strategy of photosensitizer (PS) modification by polymeric materials to enhance
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Recently, a chitosan-based hydrogel containing 0.5% hydroxypropyl methylcellulose and
toluidine blue O with high adhesiveness was developed for the treatment of periodontitis [165]. Two
major periodontal pathogens, A. actinomycetemcomitans and P. gingivalis biofilms, were used to
evaluate the bactericidal effects. When the irradiation power was higher than 32.4 J·cm−2 using 630
nm light, a significant reduction in survival rate was observed in both single-species periodontal
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periodontal pathogens, A. actinomycetemcomitans and P. gingivalis biofilms, were used to evaluate the
bactericidal effects. When the irradiation power was higher than 32.4 J·cm−2 using 630 nm light, a
significant reduction in survival rate was observed in both single-species periodontal biofilms [165].
Furthermore, when the light dose was increased to 54 and 108 J·cm−2 , A. actinomycetemcomitans
and P. gingivalis biofilms were completely eradicated, respectively [165]. Regarding periodontal
regeneration, two in-situ curable biomaterials, BioM1 and BioM2, were developed as support for PS
and had excellent mechanical and antimicrobial behaviors [15]. The BioM1 and BioM2 consisted of
urethane dimethacrylate and a tri-armed oligoester-urethane methacrylate, respectively. The PS was
composed of a mixture of β-tricalcium phosphate (β-TCP) microparticles and 20 wt % photosensitizer
mTHPC (Figure 7B). The BioM2 + PS with a single laser-illumination (652 nm) caused total suppression
of P. gingivalis, while BioM2 + PS with repeated irradiation reduced 3.1 log in CFU counts [15].
PS binding to various cationic peptide or polymers can enhance their loading into the bacterial
cells and target periodontal pathogens (Figure 7C). It was confirmed that aPDT with chlorin e6
(Ce6) and BLC 1010 suppressed periodontopathogenic bacteria [166]. Ce6-(Lys)5 -OH (Ce6-5K)
conjugate broadened the spectrum of activity against periodontal pathogens, compared to the
pure Ce6. Ce6-5K showed a strong killing effect on almost all oral bacteria tested, and showed
at least six logs of killing for periodontal pathogens including P. gingivalis, A. actinomycetemcomitans,
and B. forsythus [167]. In addition, two types of polylysin-porphycene conjugates GlamTMPn
and BOHTMPn were synthesized to assess the development of resistance in bacterial cells [168].
The combination of polylysin-porphycene conjugates and bacterial cells was quite stable and showed
an extremely high photosensitivity on F. nucleatum with 60 s irradiation [168]. Considering the
precise targeting of aPDT, LiDps genetic construct was dual functionalized with SnCe6 and biotin
(KLFC-LiDps-B-SnCe6) for A. actinomycetemcomitans biofilm-targeting, producing light-activated
membrane disruption [169]. Streptavidin was used to couple biotinylated dodecamer to a biotinylated
anti-A. actinomycetemcomitans antibody, which increased the loading efficacy of photosensitizer onto
the bacterial cells. Light-induced activity of the targeted photosensitizer reduced the viability of
A. actinomycetemcomitans biofilm [169]. In addition, a Fotolon sensitizer, composed of Ce6 and
polyvinylpyrrolidone (PVP), obtained over 99.9% reduction in CFU in twenty Gram-positive and
thirty Gram-negative clinical anaerobic strains. The PVP increased the quantum yield and fluorescence
lifetime of Ce6, which contributed to the dispersion of particles and increased its bioavailability [170].
In recent years, nanoparticle-based PDT has become a hot research field in both tumor treatment
and antibacterial therapy [171–173]. Extensive efforts had been made on how to disturb the formation
of biofilms, and enhance the delivery of PS and its combination with bacteria to improve bactericidal
efficiency by using the nanoparticles in oral diseases [51,174,175].
For intra-pocket administration, a major disadvantage of traditional nanoparticles carrying
PS agents is the low delivery efficiency due to the drainage of gingival crevicular fluid and high
saliva fluid turnover. Therefore, efficient delivery and penetration of the antibacterial agent to
the exact site of infection is still highly desirable. In addition, real-time monitoring of the drug
consumption and distribution is another issue that should be taken into consideration. The unknown
effective dose of therapeutic agents reaching the disease site is an important uncertainty, and often
leads to over-dosing or insufficient dosing [176]. In a recent study, a novel type of multifunctional
nanoparticles Fe3 O4 -silane@Ce6/C6 was developed to trigger the aPDT for periodontal therapy,
as shown in Figure 7D [177]. Fe3 O4 and PS molecules were encapsulated with amphiphilic silane,
which formed the hydrophobic interspace between the alkyl chains of silane and the octadecyl groups
of oleic acid being bonded on the surface of Fe3 O4 NPs. The PS molecules were well dispersed inside
the nanocomposites. The hydroxyl of silane stretched out to enhance the water solubility. In addition,
to solve the real-time monitoring issue, dye Coumarin 6 (C6) hydrophobic organic molecules were also
encapsulated together inside the hydrophobic environment of silane via the hydrophobic interaction,
without increasing the particle size. Besides the imaging function with the efficient green emission
of C6, another advantage in this design was the real-time aPDT monitoring function [177]. The C6
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molecule was not sensitive to red light (630 nm wavelength) but could be co-excited with Ce6 by
405 nm wavelength. Therefore, by visual imaging monitoring of the ratio of the fluorescence of
Ce6/C6, the aPDT effect (Ce6 consumption) and distribution profile in periodontal pockets could
be monitored in real time. This facilitated the optimization of therapeutic doses and treatment
time-windows. Figure 8 shows the real-time monitoring and magnetic targeting functions of the
multifunctional nanoparticles. The in vitro antibacterial experiments showed that three single-species
periodontitis-related biofilm survival was reduced by about 4–5 orders of magnitude after 3 min of
irradiation by the 630 nm light (100 mW·cm−2 ) [177]. Therefore, the multifunctional design has great
potential for antibacterial applications to inhibit the occurrence and progression of periodontitis.
Visible light is usually used as the main light source to trigger the PS for periodontal therapy.
Red light is used as the excited light source since it can penetrate deeper than violet, blue, green,
or yellow lasers [178]. However, the limited penetration depth of visible light cannot reach deep
periodontal pocket to disturb or clear the periodontal pathogens. There is a biological tissue window
ranging from 700 nm to 1100 nm in the near-infrared (NIR) light. The excitation of NIR light provides
a deeper penetration and lower autofluorescence, and reduces phototoxicity and photodamage side
effects [179]. Titanium dioxide (TiO2 ) is widely used as a catalyst because of its high stability and good
photocatalytic activity. ROS produced by photocatalysis of TiO2 has high bactericidal and sterilizing
effects on oral pathogens [180]. However, one major concern about TiO2 application is that it can
only be activated by ultraviolet (UV) light due to its wide band gap energy of 3.2 eV. Furthermore,
the irradiation of UV light may cause DNA damage and cell death. Recently, various upconversion
nanoparticles (UCNs) have been developed to solve this problem and are applied widely in cancer
therapy. However, little research has been performed on antimicrobial and bacteriostasis. Under
near-infrared light irradiation, the UCN core converts the low energy NIR light to high energy UV light,
which induces the photocatalysis activity of TiO2 via an anti-Stokes emission process. Based on this
mechanism, a recent study synthesized a core–shell structured NaYF4 :Yb3+ , Tm3+ @TiO2 (TiO2 -UCNs)
which was applied in aPDT for periodontal pathogens (Figure 7E). The UCN cores, NaYF4 :Yb3+ , Tm3+ ,
were synthesized by thermal decomposition in an oleic acid system [181]. Polyvinylpyrolidone (PVP)
was added for the modification of the surface of UCNs. Subsequently, titanium n-butoxide served as a
titanium precursor to coat the TiO2 shell on the surface of the UCNs under hydrothermal reactions.
The results showed that TiO2 -UCNs had excellent antibacterial activity against periodontal pathogens
including P. gingivalis and F. nucleatum. Reductions of 4–5 orders of magnitude in bacteria CFU were
achieved in the light groups. At 4 h after the initial irradiation of 2.5 W·cm−2 for 5 min, the suspension
of bacteria was almost cleared when the concentration of drugs was at 2 mM. Therefore, NIR-triggered
aPDT is a promising approach for effective periodontitis treatment.

under hydrothermal reactions. The results showed that TiO2-UCNs had excellent antibacterial
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magnetic region. (Reproduced with permission from [177]. Elsevier, 2019.)

Despite of many publications on the use of aPDT to combat periodontal pathogens and biofilms,
Despite of many publications on the use of aPDT to combat periodontal pathogens and biofilms,
several problems remain. For instance, PS parameters, the strategy of surface modification and doses
several problems remain. For instance, PS parameters, the strategy of surface modification and doses
of PS, and irradiation intensity which determines the type and kinetics of bio-distribution and toxicity
of PS, and irradiation intensity which determines the type and kinetics of bio-distribution and toxicity
at the cellular and tissue level, should be strictly tested to ensure minimal toxicity. In addition,
at the cellular and tissue level, should be strictly tested to ensure minimal toxicity. In addition, the
the efficient PS delivery, organ distribution, accumulation, retention, degradation, metabolism and
efficient PS delivery, organ distribution, accumulation, retention, degradation, metabolism and
clearance properties should be investigated at the organ level. It is essential for PS to enhance the
clearance properties should be investigated at the organ level. It is essential for PS to enhance the
selectivity of the pathogens without killing the benign microflora in oral environment. Another concern
selectivity of the pathogens without killing the benign microflora in oral environment. Another
is that the irradiation intensity should be strictly and repeatedly tested before clinical application to
concern is that the irradiation intensity should be strictly and repeatedly tested before clinical
avoid oxidative damage to the host cells. In addition, in vivo studies should be performed in animal
application to avoid oxidative damage to the host cells. In addition, in vivo studies should be
models to confirm the feasibility for clinical applications. Further studies are needed to solve these
problems for clinical application to be successful.
8. Conclusions
This article reviews cutting-edge research on antibacterial properties of novel polymeric materials
against periodontal pathogens and oral biofilms. The focus was particularly on antibiotics delivery,
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functional GTR membrane, dental composite and bonding agents for decay restoration, and PS
modification for aPDT enhancement. Due to increasing resistance development, there is a need to find
delivery systems compatible with a diversity of antibacterial agents. Novel polymers offer meritorious
opportunities and are compatible with a wide range of antibiotics to combat periodontitis. Endowing
GTR membranes with antibacterial functions could not only benefit tissue regeneration, but also
lower the risk of infection. In addition, the new generation of resins for Class-V restorations offers
strong protein-repellent and antibacterial capabilities against periodontal biofilms, and is promising to
improve a wide range of dental treatments. Furthermore, polymer modification of PS could increase the
dispersion of PS and improve its bioavailability, thus enhancing the aPDT effects against periodontal
pathogens. Therefore, the novel bioactive and therapeutic polymers have great potential for treating
periodontal disease and other dental diseases.
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